1. Fujimoto, N., Y.Taniguchi, H. Sonoda, Y. Kaneko, T. Matsuzaki, T. Itoh, T. Hirai, K. Uchida, M. Ikeda, 2024. Expression patterns of aquaporins 1, 3, 5 in canine mammary gland carcinomas. Journal of Veterinary Medical Science. 86(2):168-179.

1. Ogawa, K., Y. Ohno, A. Tagashira, K. Urata, K. Satoh, N. Fujimoto, H. Sonoda, M. Ikeda, T. Matsuzaki, K. Nishiyama, H. Kunitake, Y. Goto, M. Yamasaki, 2023. Blueberry Stem Extract Prevents Lacrimal Hyposecretion in Non-obese Diabetic Mice via Activation of AMPK. In Vivo.

1. 池田正浩. 毒性学実験第四版. 血小板凝集に影響する薬物. pp23, 文英堂出版 (2023).

2. 池田正浩. 毒性学実験第四版. 腎臓に作用（利尿に影響）する薬物. pp23, 文英堂出版 (2023).

1. Nueangphuet, P., T. Hamano, T. Hirai, Y. Sakaguchi, H. Sonoda, M. Otsuka, Y. Osamu, S. Hobo, M. Ikeda, R. Yamaguchi, 2022. Rhabdomyolysis, myoglobinuric nephrosis, and crystalline nephropathy in a captive bottlenose dolphin. J. Vet. Diagn. Invest. 34(4):668-673.

2. Hoshino, Y., H. Sonoda, N. Mikoda, M. Ikeda, 2022. Upregulation of NADPH oxidase 2 contributes to renal fibrosis in pcy mice: an experimental model of nephronophthisis. Nephron 146(4)393-403.

1. Hoshinoi, Y., H. Sonoda, N. Mikoda, M. Ikeda, 2021. Upregulation of NADPH oxidase 2 contributes to renal fibrosis in pcy mice: an experimental model of nephronophthisis. Nephron:1-11.

2. Oshikawa-Hori, S., N. Yokota-Ikeda, H. Sonoda, Y. Sasaki, M. Ikeda, 2021. Reduced urinary release of AQP1- and AQP2-bearing extracellular vesicles in patients with advanced chronic kidney disease. Physiol. Rep. 9(17):e15005.

3. Yamasaki, M., Y. Yamasaki, R. Furusho, H. Kimura, I. Kamei, H. Sonoda, M. Ikeda. T. Oshima, K. Ogawai, K. Nishiyama, 2021. Onion (Allium cepa L.)-derived nanoparticles inhibited LPS-Induced nitrate production, however, their intracellular incorporation by endocytosis was not involved in this effect on RAW 264 cells. Molecules 26(9):2763-2763.

1. 池田正浩. 薬理学. 獣医薬理学第二版. [日本比較薬理学・毒性学会編], pp23, 近代出版 (2021).

1. Abdeen, A., H. Sonoda, A. Kaito, S. Oshikawa-Hori, N. Fujimoto, M. Ikeda.2020. Decreased excretion of urinary exosomal aquaporin-2 in a puromycin aminonucleoside-induced nephrotic syndrome model. Int. J. Mol. Sci. 21(12):E4288-E4288.

2. 池田正浩. 腎毒性. 獣医毒性学第二版. [日本比較薬理学・毒性学会編], pp103-110, 近代出版 (2020).

3. Abdeen, A., H. Sonoda, A. Tanaka, M. Ikeda. 2020. Urinary exosomes as a possible source of kidney disease biomarkers. Role of Exosomes in Biological Communication Systems. 221-244.

1. Sinlapadeelerdkul, T., H. Sonoda, K. Uchida, G. Kitahara, M. Ikeda. 2019. Release of urinary aquaporin-2-bearing extracellular vesicles is decreased in pregnant Japanese Black cattle. J. Vet. Med. Sci. 81(11):1609-1615.

2. Oshikawa-Hori, S., N. Yokota-Ikeda, H. Sonoda, M. Ikeda. 2019. Urinary extracellular vesicular release of aquaporins patients with renal transplantation. BMC Nephrol. 20(1):216.

3. Mikoda, N., H. Sonoda, S. Oshikawa, Y. Hoshino, T. matsuzaki, M. Ikeda. 2019. A bell-shaped pattern of urinary aquaporin-2-bearing extracellular vesicle release in an experimental model of nephronophthisis. Physiol. Rep. 7(9):e14092.

4. Sonoda, H., K.H. Park, D. Nihalani, J.H. Yoon, M. Ikeda, S.H. Kwon. 2019. miRNA profiling of urinary exosomes to assess the progression of acute kidney injury. Sci. Rep. 9(1):4692.

5. Sonoda, H., S. Oshikawa-Hori, M. Ikeda. 2019. An early decrease in release of aquaporin-2 in urinary extracellular vesicles after cisplatin treatment in rats. cells. 8(2):pill:E139.

6. Hoshino, Y., H. Sonoda, R. Nishimura, K. Mori, K. Ishibashi, M. Ikeda. 2019. Involvement of the NADPH oxidase 2 pathway in renal ixidative stress in Aqp11-/-mice. Biochem. Biophys. Rep. 17:169-176.

7. 山本集士、鳥巣至道、網谷龍太、黒川亮介、平野伸一、BHE. ONG、園田紘子、金子泰之、水谷真也、池田正浩、延永清和. 健常犬における水素ガス吸入の安全性および吸入麻酔時の酸化ストレス抑制効果についての検討. 比較統合医療学会誌 26(2), 5-12(2019).

1. Asvapromtada, S., H. Sonoda, M. Kinouchi, S. Oshikawa, S. Takahashi, Y. Hoshino, T. Sinlapadeelerdkul, N. Yokota-Ikeda, T. Matsuzaki, M. Ikeda. 2018. Characterization of urinary exosomal release of aquaporin-1 and -2 after renal ischemia-reperfussion in rats. Am. J. Physiol. Renal Physiol. 314(4):F584-F601.

2. 池田正浩. 腎疾患にかかわるエクソソーム. 医療を変えるエクソソーム, 174-181, 株式会社化学同人 (2018).

1. Abdeen, A., H. Sonoda, S. Oshikawa, Y. Hoshino, H. Kondo, M. Ikeda. 2016. Acetazolamide enhances the release of urinary exosomal aquaporin-1. Nephrol. Dial. Transplant. 31(10):1623-1632.

2. Kaneko, Y., S. Torisu, T. Kobayashi, S. Mizutani, N. Tsuzuki, H. Sonoda, M. Ikeda, K. Naganobu. 2016. Arterial blood gas anomaly in canine hepatobiliary disease. J. Vet. Med. Sci. 77:1633-1638.

3. 園田紘子, 池田正浩. 尿中細胞外小胞(エクソゾーム)と腎疾患. 生体の科学 67(5), pp406-407, 医学書院 (2016).

4. Oshikawa, S., H. Sonoda, M. Ikeda. 2016. Aquaporins in urinary extracellular vesicles (exosomes). Int.J.Mol.sci. 17(6):pill:E957.

5.北原豪, 池田正浩, 梅村崇志, 末吉益雄, 大澤健司, 森田哲夫, 村上昇. 産業動物分野の卒後教育に関する全国アンケート調査. 獣医畜産新報 (2016).

1. Ikeda, M., T. Matsuzaki. 2015. Regulation of aquaorins by vasopressin in the kidney. Vitam. Horm. 98:307-337.

2. 池田正浩. アルドステロンは腎皮質集合管細胞のmicroRNA発現調節を介してNa輸送を制御する. Fluid Management Renaissance 29, 30-33 (2015).

3. 園田紘子, 池田正浩. エクソソームと腎疾患. 血管医学 16(2), 149-157 (2015).

1. Yamasaki, M., M. Iwase, K. Kawano, Y. Sakakibara, M. Suiko, M. Ikeda, K. Nishiyama, K. 2014. Alpha Lipoic Acid supressed migration and invasion via downregulation of cell surface β1-integrin expression in badder cancer cells. J. Clin. Biochem. Nutr. 54:18-25.
2. Takahashi, S., K. Muta, H. Sonoda, A. Kato, A. Abdeen, M. Ikeda. 2014. The role of cysteine 227 in subcellular localization, water permeability, and multimerization of aquaporin-11. FEBS Open Bio. 4:315-320.

3. 池田正浩, 園田紘子. 腎疾患におけるエクソソーム. Bio Clinica 29, 30-33 (2014).

1. Abdeen, A., H. Sonoda, I. Kobayashi, G. Kitahara, and M. Ikeda. 2013. A New Method for Rapid Detection of the Mutant Allele for Chediak-Higashi Syndrome in Japanese Black Cattle. J. Vet. Med. Sci. 75:1237-1239.
2. Atochina-Vasserman, E.N., A. Biktasova, E. Abramova, D.S. Cheng, V.V. Polosukhin, H. Tanjore, S. Takahashi,
H. Sonoda, L. Foye, C. Venkov, S.V. Ryzhov, S. Novitskiy, N. Shlonimskaya, M. Ikeda, T.S. Blackwell, W.E. Lawson,
A.J. Gow, R.C. Harris, M.M. Dikov, and E.E. Tchekneva. 2013. Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress. Am. J. Physiol. Renal Physiol. 304:F1295-F1307.
3. Higashijima, Y., H. Sonoda, S. Takahashi, H. Kondo, K. Shigemura, M. Ikeda 2013. Excretion of urinary exosomal AQP2 in rats is regulated by vasopressin and urinary pH. Am. J. Physiol. Renal Physiol. 305:F1412-F1421.

4. 池田正浩. 血液に作用する薬. 獣医薬理学. [日本比較薬理学・毒性学会編], pp157-167, 近代出版 (2013).
5. 池田正浩. 塩類代謝と腎機能に影響する薬. 獣医薬理学. [日本比較薬理学・毒性学会編], pp168-180, 近代出版 (2013).
6. 池田正浩. 腎毒性. 獣医毒性学. [日本比較薬理学・毒性学会編], pp159-167, 近代出版 (2013).

1. Homma, T., M. Fujisawa, K. Arai, M. Ishii, T. Sada, and M. Ikeda. 2012. Spironolactone, but not eplerenone, impairs glucose tolerance in a rat model of metabolic syndrome. J. Vet. Med. Sci. 74:1015-1022.
2. Homma, T., H. Sonoda, K. Manabe, K. Arai, M. Mizuno, T. Sada, T. and M. Ikeda. 2012. Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model for chronic cardiorenal syndrome. Am. J. Physiol. Renal Physiol. 302:F750-F761.

1. Ikeda, M., A. Andoo, M. Shimono, N. Takamatsu, A. Taki, W. Matsushita, T. Uechi, T. Matsuzaki, N. Kenmochi, K. Takata, S. Sasaki, K. Ito, and K. Ishibashi. 2011. The NPC motif of aquaporin-11, unlike the NPA motif of known aquaporins, is essential for full expression of molecular function. J. Biol. Chem. 286:3342-3350.

1. Sonoda, H., W. Prachasilchai, H. Kondo, N. Yokota-Ikeda, S. Oshikawa, K. Ito, and M. Ikeda. 2010. The protective effect of radicicol against renal ischemia--reperfusion injury in mice. J. Pharmacol. Sci. 112:242-246

2. 伊藤勝昭, 岩見暁人, 飯田真志, 桂裕美, 池田正浩 .二種のラット頻尿（過活動膀胱および膀胱炎）モデルにおける排尿行動，排尿動態の比較. 宮崎大学農学部研究報告 56, 153-161 (2010).
3. 園田紘子, 髙橋早樹, 池田正浩. Sepsis / MOFとAKI. ICUとCCU 34, 283-289 (2010).

1. Sonoda, H., N. Yokota-Ikeda, S. Oshikawa, Y. Kanno, K. Yoshinaga, K. Uchida, Y. Ueda, K. Kimiya, S. Uezono, A. Ueda, K. Ito, and M. Ikeda. 2009. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 297:F1006-F1016.
2. Sharyo, S., K. Kumagai, N. Yokota-Ikeda, K. Ito, and M. Ikeda. 2009. Amelioration of renal ischemia-reperfusion injury by inhibition of IL-6 production in the poloxamer 407-induced mouse model of hyperlipidemia. J. Pharmacol. Sci. 110:47-54.
3. Prachasilchai, W., H. Sonoda, N. Yokota-Ikeda, K. Ito, T. Kudo, K. Imaizumi, and M. Ikeda. 2009. The protective effect of a newly developed molecular chaperone-inducer against mouse ischemic acute kidney injury. J. Pharmacol. Sci. 109:311-314.

4. 池田正浩. 腎毒性. 新獣医毒性 [日本比較薬理学・毒性学会編], pp101-107, 近代出版 (2009).

1. Prachasilchai, W., H. Sonoda, N. Yokota-Ikeda, S. Oshikawa, C. Aikawa, K. Uchida, K. Ito, T. Kudo, K. Imaizumi, and M. Ikeda. 2008. A protective role of unfolded protein response in mouse ischemic acute kidney injury. Eur. J. Pharmacol. 592:138-145.
2. Sharyo, S., N. Yokota-Ikeda, M. Mori, K. Kumagai, K. Uchida, K. Ito, M. Burne-Taney, H. Rabb, and M. Ikeda. 2008.Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int. 74:577-584.
3. Morell, C.N., H. Sun, M. Ikeda, J.C. Beique, A.M. Swaim, E. Mason, T.V. Martin, L.E. Thompson, O. Gozen, D. Ampagoomian, R. Sprengel, J. Rothstein, N. Faraday, R. Huganir, and C.J. Lowenstein. 2008. Glutamate mediates platelet activation through the AMPA receptor. J. Exp. Med. 205:575-584.
4. Ito, K., A. Iwami, H. Katsura, and M. Ikeda. 2008. Therapeutic effects of the putative P2X(3)/P2X (2/3) antagonist A-317491 on cyclophosphamide-induced cystitis in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 273:483-490.
5. Kato, T., T. Nasu, H. Sonoda, Ito, K.-M., M. Ikeda,and K. Ito. 2008. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension. J. Cardiovasc. Pharmacol. 51:18-23 .

6. 池田正浩. 哺乳類の水代謝. 水とからだの事典 [佐々木成、石橋賢一編], pp119-123, 朝倉書店 (2008).
7. 園田紘子, 池田正浩, 池田直子. 急性腎障害と多臓器不全、敗血症. 内科. 102, 26-31 (2008).
8. 池田正浩. 血圧I (副交感神経系に作用する薬物). 薬理学・毒性学実験第3版 [比較薬理学・毒性学会編], pp80-83, 文永堂出版 (2008).
9. 池田正浩. 血圧II (交感神経系に作用する薬物). 薬理学・毒性学実験第3版 [比較薬理学・毒性学会編], pp84-85, 文永堂出版 (2008).
10. 伊藤勝昭、池田正浩. 血小板凝集に影響する薬物. 薬理学・毒性学実験第3版 [比較薬理学・毒性学会編], pp102-104, 文永堂出版 (2008).
11. 池田正浩. 腎に作用 (利尿に影響) する薬物. 薬理学・毒性学実験第3版 [比較薬理学・毒性学会編], pp119-120, 文永堂出版 (2008).
12. 新明解獣医学辞典 [新獣医学辞典編集委員会編] 池田正浩. アトルバスタチン，アンチトロンビン，活性化部分トロンボプラスチン時間，血液凝固抑制薬，血小板由来増殖因子，鉱質コルチコイド，腎上皮ナトリウムチャネル阻害薬，スタチン系薬，組織性プラスミノゲンアクチベーター，チロシンキナーゼ型受容体，鎮痛薬腎症，DL-メチオニン，低分子ヘパリン，ドルゾラミド，尿崩症治療薬，ヒアルロン酸，ヒドロキシメチルグルタリルCoAリダクターゼ(HMG-CoAリダクターゼ），ピレタニド，プラバスタチン，プロタミン，ヘパラン硫酸，ヘパリン. チクサン出版 (2008).

1. Honda, N., K. Ohnishi, T. Fujishiro, M. Ikeda, and Ito, K. 2007. Alteration of release and roles of ADP and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome. Am. J. Vet. Res. 68:1399-1406 .
2. Ikeda, M. 2007. Characterization of functional P2X1 receptors in mouse megakaryocytes. Thromb. Res. 119:343-353.

1. Ikeda, M., Y. Gunji, H. Sonoda, S. Oshikawa, M. Shimono, A. Horie, K. Ito, and S. Yamasaki. 2006. Inhibitory effect of tyrphostin 47 on Shiga toxin-induced cell death. Eur. J. Pharmacol. 546:36-39.
2. Ikeda, M., P. Fong, J. Cheng, A. Boletta, F. Qian, X.M. Zhang, H. Cai, G.G. Germino, and W.B. A. Guggino. 2006. regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression. Cell. Physiol. Biochem. 18:9-20.
3. Beitz, E., K. Liu, M. Ikeda, W.B. Guggino, P. Agre, and M. Yasui. 2006. Determinants of AQP6 trafficking to intracellular sites vs. to the plasma membrane in transfected mammalian cells. Biol. Cell. 98:101-109.

4. Ikeda, M., W. Prachasilchai, M. Burne-Taney, H. Rabb, and N. Yokota-Ikeda. 2006. Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation. Drug Discov. Today. 11: 364-370